Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by Clinterooon Jan 10, 2014 4:30pm

119 Views

Post# 22079842

RE:p.p.

I doubt they would lower the price. The PP was only announced two days ago.

I am not sure if there is a never ending supply at .15 or not but what we really need is some volume. For the past several weeks we have averaged about 100,000 shares. A mere $15,000. We need more volume, ie. a million or more shares traded for a few days.

The PP has not had any real effect on voume.

So I guess the market is not as enamoured about the PP as homerun is. Gee, what a surprise.

Anyway, I think the bottom line is we still need to finalize the deals with Obagi and Wanbang. All else is secondary. Yes the PP ensures we have money for the next while but without deals we have nothing.

Bullboard Posts

Eminent acquires promising Nevada gold project